TELY TelyRx Holdings Inc.

1.014USD1.450 CAD · TSX+2.11%Mkt Cap: 27.41M USDP/E: —

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with…

Key Statistics

Company
Market Cap27.41M USD
Enterprise Value53.45M USD
Revenue (TTM)79.46M USD
Gross Profit23.32M USD
Net Income (TTM)-5.42M USD
Revenue/Share2.65 USD
Last Price1.014 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees—
CountryCA
SectorHealthcare
IndustryPharmaceutical Retailers
ISINCA87974Y1043
Valuation
P/E (Trailing)—
P/E (Forward)51.79
PEG—
EV/EBITDA-5.40
EV/Revenue0.67
P/S0.49
P/B5.58
EPS (TTM)-0.62 USD
EPS (Forward)0.03 USD
52W Range
0.87387% of range2.971
52W High2.971 USD
52W Low0.8738 USD
Profitability
Gross Margin54.32%
Oper. Margin-17.47%
EBITDA Margin-17.83%
Profit Margin-12.64%
ROE64.02%
ROA-54.93%
ROIC-1176.30%
ROCE—
Growth
Revenue Growth87.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-770.00K USD
CapEx (TTM)1.44M USD
FCF Margin-9.24%
FCF Yield-26.79%
Net Debt4.95M USD
Net Debt/EBITDA-0.35
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.40
Current Ratio1.91
Quick Ratio1.28
Book Value/Sh0.26 USD
Cash/Share0.17 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.146 USD
Upside (mean)+210.3%
Target Range3.146 USD – 3.146 USD
# Analysts1
Ownership
Shares Out.26.82M
Float12.27M
Insiders57.67%
Institutions0.00%
Short Interest
Short Ratio0.6d
Short % Out.0.02%
Shares Short4.92K
Short (prev mo.)2.04K
Technical
SMA 501.639 (-38.1%)
SMA 2001.824 (-44.4%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)8.85K
Avg Vol (10d)7.72K
Technical Indicators
RSI (14)21.8
MACD-0.2143
MACD Signal-0.1140
MACD Hist.-0.1003
BB Upper2.004 USD
BB Middle1.532 USD
BB Lower1.061 USD
BB Width61.49%
ATR (14)0.1069 USD
Vol Ratio (20d)4.09x

About TelyRx Holdings (TSE: TELY)

›

TelyRx Holdings (TSE: TELY) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector.

The shares were at 1.450 CAD on 19 November 2026. Its 52-week range is 1.250 CAD to 4.250 CAD: the price is 65.9% below the high and 16.0% above the low.

Its market capitalisation is 39.21M CAD.

TelyRx Holdings reports return on equity of 64.0%, an operating margin of -17.5% and revenue up 87.1% year over year.

Its debt exceeds its cash by 4.95M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 4.500 CAD is 210.3% above the current price.